Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease
- 1 May 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 90 (18) , e1618-e1626
Abstract
Objective Determining baseline predictors of future psychosis in Parkinson disease (PD) may identify those at risk for more rapidly progressive disease, i.e., a more malignant PD subtype. Methods This cohort study evaluated 423 patients with newly diagnosed PD collected as part of the Parkinson9s Progression Markers Initiative. Psychotic symptoms were assessed with the Movement Disorders Society–Unified Parkinson Disease Rating Scale item 1.2, which assesses hallucinations and psychosis over the past week. At baseline, participants completed the Scales for Outcomes in Parkinson9s Disease–Autonomic, the REM Sleep Behavior Disorder (RBD) Screening Questionnaire, and the Epworth Sleepiness Scale. Cholinergic nucleus 4 (Ch4) density was calculated for 228 participants with PD and 101 healthy controls. Results Multivariate logistic regression adjusted for age and sex found that greater autonomic symptoms (p = 0.002), RBD (p = 0.021), and excessive daytime sleepiness (EDS) (p = 0.003) at baseline were associated with increased risk of reporting psychotic symptoms on ≥2 occasions. Having 2 or 3 of these baseline symptoms was associated with lower Ch4 density (p = 0.007). In a logistic regression model adjusted for age and sex, higher Ch4 gray matter density was associated with lower risk of reporting psychotic symptoms on ≥2 occasions (odds ratio 0.96 [for an increase in density of 1 unit], p = 0.03). Conclusions This study confirms that RBD, EDS, and greater autonomic symptom burden are associated with greater risk of future psychotic symptoms in PD. Reduced Ch4 density at baseline is associated with future psychotic symptoms and a greater burden of RBD, EDS, and autonomic symptoms.Keywords
This publication has 34 references indexed in Scilit:
- Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Testing an aetiological model of visual hallucinations in Parkinson's diseaseBrain, 2011
- Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrainNeuroImage, 2008
- Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinationsParkinsonism & Related Disorders, 2006
- Prevalence and Characteristics of Dementia in Parkinson DiseaseArchives of Neurology, 2003
- Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobeBrain, 2002
- Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective StudyJournal of the American Geriatrics Society, 2000
- Mortality and hallucinations in nursing home patients with advanced Parkinson's diseaseNeurology, 1995
- Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseasesJournal of the Neurological Sciences, 1983